Moving kidney therapy from systemic modulation
toward precision guidance

Located in Caohejing Pujiang Hi-Tech Park in Minhang District, Shanghai, Podigy Biopharma is an innovative biotechnology company focused on precision therapies for kidney diseases. Precision delivery to kidney tissue and disease-mechanism research are our long-term strategic priorities. We aim to address the limitations of conventional systemic therapies in acting precisely at renal lesions and enabling more precise immune modulation.

Through a model that advances therapeutic R&D alongside platform technologies, we develop wholly owned pipelines, pursue co-development programs and build technology partnerships—extending innovative delivery capabilities to more kidney diseases.